Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Latham Group, Inc. Reports Third Quarter 2026 Financial Results
-
Safe Bulkers, Inc. Sets Date for the Third Quarter 2026 Results, Conference Call, and Webcast
-
Cricut, Inc. Reports Third Quarter 2026 Financial Results
-
Inspire Medical Systems, Inc. to Present at the Stifel 2026 Healthcare Conference
-
Mobia Medical to Participate in the 8th Annual Wolfe Research Healthcare Conference
-
Amwell® Announces Results for the Third Quarter 2026
-
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
Latigo Biotherapeutics to Participate in Upcoming Investor Conferences in November
-
Oculis Reports Q3 2026 Financial Results and Builds Momentum Toward Multiple Upcoming Pipeline Catalysts
-
BOK Financial Increases Quarterly Dividend 24% To $0.78 Per Share
-
Robo.ai Inc. Reaffirms the Upcoming Reverse Stock Split
-
Amdocs Enters the Insurance Industry Through the Acquisition of EIS, Opening a Strategic Growth Opportunity
-
Revolve Group Announces Third Quarter 2026 Financial Results
-
Agora Data Expands Auto Dealer Funding Program with More Competitive Rates and Higher Advances
-
22nd Century Group to Announce Third Quarter 2026 Results on November 16, 2026
-
Alamar Biosciences Partners with GSK on Large-Scale Proteomic Study to Advance Precision Medicine
-
Premium Global Income Split Fund Declares Monthly Distribution
-
FLINT Announces Third Quarter 2026 Financial Results
-
Premium Income Corporation Announces Monthly Distribution
-
Aura Biosciences to Participate in Upcoming Investor Conference
-
Globus Medical Acquires Synaptive Medical, Strengthening Its Position in Cranial Neurosurgery
-
First Acceptance Corporation Reports Operating Results for the Three and Nine Months Ended September 30, 2026
-
Mulvihill Split Preferred Share ETF Declares Monthly Distribution
-
Mulvihill Canadian Bank ETF Declares Monthly Distribution
-
Flywire Reports Third Quarter 2026 Financial Results
-
Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution
-
Curaleaf Reports Third Quarter 2026 Results: Record Revenue and Robust Profitability
-
AMGEN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
-
RAMACO RESOURCES REPORTS THIRD QUARTER 2026 RESULTS
-
Red Rock Resorts Announces Third Quarter 2026 Results
-
Transcat Reports Strong Fiscal Second Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growth and Significant Service Gross Margin Expansion
-
Key Tronic Corporation Announces Results for the First Quarter of Fiscal 2027
-
The Manitowoc Company Reports Strong Third-Quarter 2026 Results; Raises Full Year Guidance
-
Mirum Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
-
Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution
-
Mulvihill Premium Yield Fund Declares Monthly Distribution for Its ETF Class
-
AtriCure Reports Third Quarter 2026 Financial Results
-
Nurix Therapeutics Announces Sanofi’s Decision to Discontinue Development of STAT6 Degrader SAR448272
-
SLR Investment Corp. Announces Quarter Ended September 30, 2026 Financial Results
-
Ultragenyx Reports Third Quarter 2026 Financial Results, Announces Substantial Expense Reductions, and Reaffirms Profitability in 2027
-
Skyworks Begins New Chapter Following Qorvo Combination; Reports Fourth Quarter and Fiscal 2026 Results
-
Aquestive Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
-
Avis Budget Group Reports Third Quarter 2026 Results
-
Mulvihill Split Capital Share ETF Declares Monthly Distribution
-
Greif Reports Fourth Quarter and Fiscal 2026 Results
-
Denali Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights
-
United Fire Group, Inc. reports third quarter 2026 results
-
Ardelyx Reports Third Quarter 2026 Financial Results and Provides Business Update
-
Atlanticus to Participate in KBW Fintech Ecosystem Conference
-
Monte Rosa Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)


